Targeting xanthine oxidase degradation via PROTAC technology for the treatment of hyperuricaemia

Key Points

• The aim is to explore the potential of PROTAC technology in degrading xanthine oxidase to treat hyperuricemia.
• Utilization of PROTAC technology to target and degrade xanthine oxidase
• Analysis of uric acid levels pre- and post-intervention
• Evaluation of systemic effects of xanthine oxidase degradation
• Effective reduction of serum uric acid levels observed after treatment
• Significant improvement in associated symptoms of hyperuricemia
• Demonstrated potential for PROTAC as a therapeutic approach in metabolic disorders